Skip Navigation


Carcinogenesis Advance Access originally published online on September 3, 2004
Carcinogenesis 2004 25(12):2325-2335; doi:10.1093/carcin/bgh274
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
25/12/2325    most recent
bgh274v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Box, A. H.
Right arrow Articles by Demetrick, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Box, A. H.
Right arrow Articles by Demetrick, D. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis vol.25 no.12 © Oxford University Press 2004; all rights reserved.

ARTICLE

Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines

Adrian Harold Box1,–3 and Douglas James Demetrick1,–5

1 Department of Pathology, 2 Department of Oncology, 3 Department of Medical Biochemistry and 4 The University of Calgary and Calgary Laboratory Services, Calgary, Alberta, Canada, T2N 4N1

5 To whom correspondence should be addressed Email: demetric{at}ucalgary.ca

Flow cytometric analysis of fibroblasts, normal breast epithelial cells and breast or other cancer cell lines identified variation in the abilities of cell lines to undergo cell cycle arrest as a response to hypoxia. Human mammary epithelial cells (HMEC), normal fibroblasts (Hs68 and WI38), HeLa cervical carcinoma and HTB-30 breast carcinoma cells arrest in G1/S in response to severe hypoxia. Hep3B hepatocellular carcinoma cells did not exhibit orderly G1/S arrest in response to severe hypoxia. We found a general decrease in p16INK4a (p16) mRNA levels, with an associated decrease in p16 protein levels in both normal cells and in cancer cells, regardless of their cell cycle response to hypoxia. p27 protein levels did not correlate with the cell line's ability to enter a hypoxic G1/S arrest. Furthermore, cell lines that underwent G1/S arrest showed decreased expression of hypoxia inducible factor 1 (HIF-1{alpha}) and at least one member of INK4 or Sdi cell cycle kinase inhibitors families after 12–24 h of hypoxia. Conversely, Hep3B, which did not exhibit orderly hypoxia-associated G1/S arrest, also did not show decreased HIF-1{alpha}, INK4 or Sdi protein levels in hypoxia. Furthermore, Hep3B showed constitutive activating phosphorylation of Akt and inhibitory phosphorylation of GSK3ß, which was the opposite pattern to that exhibited by the cell lines showing the G1/S arrest phenotype. Inhibition of GSK3ß by lithium chloride treatment of HeLa cells converted the HIF-1{alpha}, p16 and p27 loss to levels unchanged by hypoxic exposure. Our results suggest that regulation of the cell cycle during hypoxia in either normal or cancer cells is not simply due to up-regulation of cell cycle kinase inhibitors. Furthermore, decreased protein expression of HIF-1{alpha}, p16 and p27 was associated with both a hypoxia-induced G1/S arrest phenotype and increased GSK3ß activity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
J. G. Madson, D. T. Lynch, J. Svoboda, R. Ophardt, J. Yanagida, S. K. Putta, A. Bowles, C. S. Trempus, R. W. Tennant, and L. A. Hansen
Erbb2 Suppresses DNA Damage-Induced Checkpoint Activation and UV-Induced Mouse Skin Tumorigenesis
Am. J. Pathol., June 1, 2009; 174(6): 2357 - 2366.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Klatte, D. B. Seligson, S. B. Riggs, J. T. Leppert, M. K. Berkman, M. D. Kleid, H. Yu, F. F. Kabbinavar, A. J. Pantuck, and A. S. Belldegrun
Hypoxia-Inducible Factor 1{alpha} in Clear Cell Renal Cell Carcinoma
Clin. Cancer Res., December 15, 2007; 13(24): 7388 - 7393.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Z. F. Yang, R. T.P. Poon, Y. Liu, C. K. Lau, D. W. Ho, K. H. Tam, C. T. Lam, and S. T. Fan
High doses of tyrosine kinase inhibitor PTK787 enhance the efficacy of ischemic hypoxia for the treatment of hepatocellular carcinoma: dual effects on cancer cell and angiogenesis.
Mol. Cancer Ther., September 1, 2006; 5(9): 2261 - 2270.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.